[HTML][HTML] Neuropathology of Alzheimer's disease
JA Trejo-Lopez, AT Yachnis, S Prokop - Neurotherapeutics, 2023 - Elsevier
The key pathological hallmarks—extracellular plaques and intracellular neurofibrillary
tangles (NFT)—described by Alois Alzheimer in his seminal 1907 article are still central to …
tangles (NFT)—described by Alois Alzheimer in his seminal 1907 article are still central to …
Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases
Pathological alterations to the locus coeruleus, the major source of noradrenaline in the
brain, are histologically evident in early stages of neurodegenerative diseases. Novel MRI …
brain, are histologically evident in early stages of neurodegenerative diseases. Novel MRI …
In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer's disease pathology and cognitive decline
Several autopsy studies recognize the locus coeruleus (LC) as the initial site of
hyperphosphorylated TAU aggregation, and as the number of LC neurons harboring TAU …
hyperphosphorylated TAU aggregation, and as the number of LC neurons harboring TAU …
Molecular characterization of selectively vulnerable neurons in Alzheimer's disease
K Leng, E Li, R Eser, A Piergies, R Sit, M Tan… - Nature …, 2021 - nature.com
Alzheimer's disease (AD) is characterized by the selective vulnerability of specific neuronal
populations, the molecular signatures of which are largely unknown. To identify and …
populations, the molecular signatures of which are largely unknown. To identify and …
The cerebellum in Alzheimer's disease: evaluating its role in cognitive decline
The cerebellum has long been regarded as essential only for the coordination of voluntary
motor activity and motor learning. Anatomical, clinical and neuroimaging studies have led to …
motor activity and motor learning. Anatomical, clinical and neuroimaging studies have led to …
[HTML][HTML] The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer's disease
Alzheimer's disease (AD) is neuropathologically characterized by the intracellular
accumulation of hyperphosphorylated tau and the extracellular deposition of amyloid-β …
accumulation of hyperphosphorylated tau and the extracellular deposition of amyloid-β …
Long road to ruin: noradrenergic dysfunction in neurodegenerative disease
D Weinshenker - Trends in neurosciences, 2018 - cell.com
It has been known for decades that degeneration of the locus coeruleus (LC), the major
noradrenergic nucleus in the brain, occurs in both Alzheimer's disease (AD) and Parkinson's …
noradrenergic nucleus in the brain, occurs in both Alzheimer's disease (AD) and Parkinson's …
[HTML][HTML] Cerebral iron deposition in neurodegeneration
Disruption of cerebral iron regulation appears to have a role in aging and in the
pathogenesis of various neurodegenerative disorders. Possible unfavorable impacts of iron …
pathogenesis of various neurodegenerative disorders. Possible unfavorable impacts of iron …
Late-onset Alzheimer disease
GD Rabinovici - Continuum: Lifelong Learning in Neurology, 2019 - journals.lww.com
PURPOSE OF REVIEW Alzheimer disease (AD) is the most common cause of late-onset
dementia. This article describes the epidemiology, genetic and environmental risk factors …
dementia. This article describes the epidemiology, genetic and environmental risk factors …
[HTML][HTML] Biomarkers for Alzheimer's disease early diagnosis
E Ausó, V Gómez-Vicente, G Esquiva - Journal of Personalized Medicine, 2020 - mdpi.com
Alzheimer's disease (AD) is the most common cause of dementia, affecting the central
nervous system (CNS) through the accumulation of intraneuronal neurofibrillary tau tangles …
nervous system (CNS) through the accumulation of intraneuronal neurofibrillary tau tangles …